» Articles » PMID: 33211274

Fetal Growth Restriction: Does an Integrated Maternal Hemodynamic-Placental Model Fit Better?

Overview
Journal Reprod Sci
Publisher Springer
Date 2020 Nov 19
PMID 33211274
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

In recent years, a growing interest has arisen regarding the possible relationship between adverse pregnancy outcomes (APOs) and inadequate maternal hemodynamic adaptations to the pregnancy. A possible association between "placental syndromes," such as preeclampsia (PE) and fetal growth restriction (FGR), and subsequent maternal cardiovascular diseases (CVD) later in life has been reported. The two subtypes of FGR show different pathogenetic and clinical features. Defective placentation, due to a poor trophoblastic invasion of the maternal spiral arteries, is believed to play a central role in the pathogenesis of early-onset PE and FGR. Since placental functioning is dependent on the maternal cardiovascular system, a pre-existent or subsequent cardiovascular impairment may play a key role in the pathogenesis of early-onset FGR. Late FGR does not seem to be determined by a primary abnormal placentation in the first trimester. The pathological pathway of late-onset FGR may be due to a primary maternal cardiovascular maladaptation: CV system shows a flat profile and remains similar to those of non-pregnant women. Since the second trimester, when the placenta is already developed and increases its functional request, a hypovolemic state could lead to placental hypoperfusion and to an altered maturation of the placental villous tree and therefore to an altered fetal growth. Thus, this review focalizes on the possible relationship between maternal cardiac function and placentation in the development of both early and late-onset FGR. A better understanding of maternal hemodynamics in pregnancies complicated by FGR could bring various benefits in clinical practice, improving screening and therapeutic tools.

Citing Articles

The role of 1-Deoxysphingolipids and Polyamines in the pathogenesis of placental syndrome.

Guleroglu F, Cetin A, Coskun G, Caliskan M, Karaduman F, Bilginer C BMC Pregnancy Childbirth. 2025; 25(1):51.

PMID: 39844083 PMC: 11753022. DOI: 10.1186/s12884-025-07175-1.


Fatty Acid Metabolism Disruptions: A Subtle yet Critical Factor in Adverse Pregnancy Outcomes.

Cao X, Li M, Shao C, Shi J, Zhang T, Xie F Int J Biol Sci. 2024; 20(15):6018-6037.

PMID: 39664564 PMC: 11628336. DOI: 10.7150/ijbs.103404.


Impaired maternal central hemodynamics precede the onset of vascular disorders of pregnancy at high altitude.

Wiegel R, Baker K, Calderon-Toledo C, Gomez R, Gutierrez-Cortez S, Houck J Am J Physiol Heart Circ Physiol. 2024; 328(1):H174-H185.

PMID: 39657993 PMC: 11901344. DOI: 10.1152/ajpheart.00520.2024.


The central role of creatine and polyamines in fetal growth restriction.

Di Giorgio E, Xodo S, Orsaria M, Mariuzzi L, Picco R, Tolotto V FASEB J. 2024; 38(23):e70222.

PMID: 39614665 PMC: 11607630. DOI: 10.1096/fj.202401946R.


Incidence and determinants of low birth weight in Peninsular Malaysia: A multicentre prospective cohort study.

Mansor E, Ahmad N, Zulkefli N, Lim P PLoS One. 2024; 19(7):e0306387.

PMID: 38995940 PMC: 11244833. DOI: 10.1371/journal.pone.0306387.


References
1.
Tiralongo G, Pisani I, Vasapollo B, Khalil A, Thilaganathan B, Valensise H . Effect of a nitric oxide donor on maternal hemodynamics in fetal growth restriction. Ultrasound Obstet Gynecol. 2017; 51(4):514-518. DOI: 10.1002/uog.17454. View

2.
Perry H, Lehmann H, Mantovani E, Thilaganathan B, Khalil A . Are maternal hemodynamic indices markers of fetal growth restriction in pregnancies with a small-for-gestational-age fetus?. Ultrasound Obstet Gynecol. 2019; 55(2):210-216. DOI: 10.1002/uog.20419. View

3.
Meher S, Duley L, Hunter K, Askie L . Antiplatelet therapy before or after 16 weeks' gestation for preventing preeclampsia: an individual participant data meta-analysis. Am J Obstet Gynecol. 2016; 216(2):121-128.e2. DOI: 10.1016/j.ajog.2016.10.016. View

4.
Learmont J, Poston L . Nitric oxide is involved in flow-induced dilation of isolated human small fetoplacental arteries. Am J Obstet Gynecol. 1996; 174(2):583-8. DOI: 10.1016/s0002-9378(96)70432-5. View

5.
Figueras F, Caradeux J, Crispi F, Eixarch E, Peguero A, Gratacos E . Diagnosis and surveillance of late-onset fetal growth restriction. Am J Obstet Gynecol. 2018; 218(2S):S790-S802.e1. DOI: 10.1016/j.ajog.2017.12.003. View